Document is current

Any future updates will be listed below

Targeting of the WT191–138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination

Crossref DOI link: https://doi.org/10.1007/s00262-016-1938-y

Published Online: 2016-11-28

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark